Corvaia; Nathalie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Corvaia; Nathalie.The latest application filed is for "novel anti-igf-ir antibodies and uses thereof".

Company Profile

0.19.26

Corvaia; Nathalie - Boulogne FR
Corvaia; Nathalie - Collonges Sous Saleve FR
Corvaia; Nathalie - Collonges Sous Saleves FR
Corvaia; Nathalie - Archamps FR
Corvaia; Nathalie - St. Julien En Genevois FR
Corvaia; Nathalie - Saint Julien en Genevois FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Igf-1r Specific Antibodies Useful In The Detection And Diagnosis Of Cellular Proliferative Disorders App 20150078996 - Goetsch; Liliane ; et al.	2015-03-19
Novel Anti-igf-ir Antibodies And Uses Thereof App 20150079080 - Goetsch; Liliane ; et al.	2015-03-19
Anti-IGF-IR antibodies and uses thereof Grant 8,945,871 - Goetsch , et al. February 3, 2	2015-02-03
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Grant 8,808,999 - Goetsch , et al. August 19, 2	2014-08-19
Novel Homogeneous Humanized Antiproliferation Antibodies App 20130303734 - Goetsch; Liliane ; et al.	2013-11-14
Novel Anti-igf-ir Antibodies And Uses Thereof App 20130273031 - GOETSCH; LILIANE ; et al.	2013-10-17
Novel Anti-igf-ir Antibodies And Uses Thereof App 20130125252 - GOETSCH; Liliane ; et al.	2013-05-16
Anti-IGF-IR antibodies and uses thereof Grant 8,420,085 - Goetsch , et al. April 16, 2	2013-04-16
Igf-1r Specific Antibodies Useful In The Detection And Diagnosis Of Cellular Proliferative Disorders App 20130084243 - Goetsch; Liliane ; et al.	2013-04-04
Anti-IGF-IR antibodies and uses thereof Grant 8,361,461 - Goetsch , et al. January 29, 2	2013-01-29
IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders Grant 8,344,112 - Goetsch , et al. January 1, 2	2013-01-01
Novel Anti-igf-ir And/or Anti-insulin/igf-i Hybrid Receptors Antibodies And Uses Thereof App 20120208721 - GOETSCH; Liliane ; et al.	2012-08-16
Novel Anti-igf-ir Antibodies And Uses Thereof App 20120183559 - GOETSCH; Liliane ; et al.	2012-07-19
Anti-jam-a Antibodies App 20120156191 - Goetsch; Liliane ; et al.	2012-06-21
Anti-IGF-IR antibodies and uses thereof Grant 8,168,410 - Goetsch , et al. May 1, 2	2012-05-01
Anti-IGF-IR antibodies and uses thereof Grant 8,124,079 - Goetsch , et al. February 28, 2	2012-02-28
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Grant 8,101,180 - Goetsch , et al. January 24, 2	2012-01-24
Anti-JAM-A antibodies Grant 8,071,730 - Goetsch , et al. December 6, 2	2011-12-06
Novel Anti-igf-ir Antibodies And Uses Thereof App 20110183376 - GOETSCH; Liliane ; et al.	2011-07-28
Novel Anti-igf-ir Antibodies And Uses Thereof App 20110091479 - GOETSCH; Liliane ; et al.	2011-04-21
Anti-IGF-IR antibodies and uses thereof Grant 7,914,784 - Goetsch , et al. March 29, 2	2011-03-29
Novel Anti-igf-ir And/or Anti-insulin/igf-i Hybrid Receptors Antibodies And Uses Thereof App 20110014122 - GOETSCH; Liliane ; et al.	2011-01-20
Anti-igf-ir antibodies and uses thereof Grant 7,854,930 - Goetsch , et al. December 21, 2	2010-12-21
Igf-1r Specific Antibodies Useful In The Detection And Diagnosis Of Cellular Proliferative Disorders App 20100215573 - Goetsch; Liliane ; et al.	2010-08-26
Novel Anti-proliferation Antibodies App 20100092455 - Goetsch; Liliane ; et al.	2010-04-15
Novel Anti-IGF-IR Antibodies and Uses Thereof App 20090265797 - Goetsch; Liliane ; et al.	2009-10-22
Novel anti-igf-ir antibodies and uses thereof App 20090214525 - Goetsch; Liliane ; et al.	2009-08-27
Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine App 20090181042 - Corvaia; Nathalie ; et al.	2009-07-16
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Grant 7,553,485 - Goetsch , et al. June 30, 2	2009-06-30
Method of generating and/or increasing an immune response against RSV Grant 7,524,627 - Corvaia , et al. April 28, 2	2009-04-28
Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine App 20090036367 - Corvaia; Nathalie ; et al.	2009-02-05
Novel anti-IGF-IR antibodies and uses thereof App 20080286198 - Goetsch; Liliane ; et al.	2008-11-20
Novel anti-IGF-IR antibodies and uses thereof App 20080193445 - Goetsch; Liliane ; et al.	2008-08-14
Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodies App 20080063639 - Goetsch; Liliane ; et al.	2008-03-13
Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine Grant 7,309,494 - Corvaia , et al. December 18, 2	2007-12-18
Anti-IGF-IR antibodies and uses thereof Grant 7,241,444 - Goetsch , et al. July 10, 2	2007-07-10
Immunostimulant bacterial membrane fractions in cancer treatment Grant 7,033,591 - Libon , et al. April 25, 2	2006-04-25
Novel anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof App 20050249730 - Goetsch, Liliane ; et al.	2005-11-10
Novel anti-IGF-IR antibodies and uses thereof App 20050084906 - Goetsch, Liliane ; et al.	2005-04-21
Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine App 20040175395 - Corvaia, Nathalie ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.